| [1] |
Schillinger M，Sabeti S，Loewe C，et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J]. N Engl J Med，2006，354（18）:1879-1888.
|
| [2] |
Jia X，Zhang J，Zhuang B，et al. Acotec drug-coated balloon catheter: randomized，multicenter，controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial[J]. JACC Cardiovasc Interv，2016，9（18）:1941-1949.
|
| [3] |
Debing E，Aerden D，Vanhulle A，et al. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial[J]. J Cardiovasc Surg（Torino），2017，58（4）:528-534.
|
| [4] |
Ramaiah V，Gammon R，Kiesz S，et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection[J]. J Endovasc Ther，2006，13（5）:592-602.
|
| [5] |
McKinsey JF，Zeller T，Rocha-Singh KJ，et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study[J]. JACC Cardiovasc Interv，2014，7（8）:923-933.
|
| [6] |
Roberts D，Niazi K，Miller W，et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca?? trial[J].Catheter Cardiovasc Interv，2014，84（2）:236-244.
|
| [7] |
Tepe G，Zeller T，Albrecht T，et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg[J]. N Engl J Med，2008，358（7）:689-699.
|
| [8] |
Werk M，Albrecht T，Meyer DR，et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial[J]. Circ Cardiovasc Interv，2012，5（6）:831-840.
|
| [9] |
Brodmann M，Rief P，Froehlich H，et al. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty（PTA）in femoropopliteal stent reobstructions: a controlled，randomized pilot trial[J]. Cardiovasc Intervent Radiol，2013，36（1）:69-74.
|
| [10] |
李伟浩，张韬，沈晨阳.下肢动脉血管成形术后再狭窄的腔内治疗进展[J].中华医学杂志，2014，（32）：2553-2556.
|
| [11] |
Stavroulakis K，Bisdas T，Torsello G，et al. Combined Directional Atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease[J]. J Endovasc Ther，2015，22（6）:847-852.
|
| [12] |
Soga Y，Tomoi Y，Sato K，et al. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease[J]. Cardiovasc Interv Ther，2013，28（3）:250-257.
|
| [13] |
Sixt S，Carpio COG，Treszl A，et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries[J]. J Vasc Surg，2013，58（3）:682-686.
|
| [14] |
Zeller T, Rastan A, Macharzina R，. Atherectomy and drug-coated balloon angioplasty for long and calcified femoropopliteal lesions: The DEFINITIVE AR trial[C]. VIVA 2014:429-436.
|
| [15] |
Cioppa A，Stabile E，Popusoi G，et al. Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon：One-year single centre clinical results[J]. Cardiovasc Revasc Med，2012，13（4）:219-223.
|
| [16] |
Schnorr B，Albrecht T. Drug-coated balloons and their place in treating peripheral arterial disease[J]. Expert Rev Med Devices，2013，10（1）:105-114.
|
| [17] |
Fanelli F，Cannavale A，Gazzetti M，et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease[J]. Cardiovasc Intervent Radiol，2014，37（4）:898-907.
|
| [18] |
郭建明，谷涌泉，郭连瑞，等. Turbohawk斑块切除系统治疗下肢动脉硬化闭塞病变[J].中国普通外科杂志，2015，（6）:915-916.
|
| [19] |
Mendes BC，Oderich GS，Fleming MD，et al. Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices[J]. J Vasc Surg，2014，59（2）:359-367.
|
| [20] |
Wholey M. The role of embolic protection in peripheral arterial atherectomy[J]. Tech Vasc Interv Radiol，2011，14（2）:65-74.
|
| [21] |
Shammas NW，Dippel EJ，Coiner D，et al. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry[J]. J Endovasc Ther，2008，15（3）:270-276.
|